Related Experiment Video

Updated: Jun 18, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

Getting with the ACC/AHA guidelines for the treatment of chronic angina as a disease state

Prakash C Deedwania1, Enrique V Carbajal

  • 1Cardiology Division, Department of Medicine, VA Central California Health Care System/UCSF Program, Fresno, CA, USA.

Reviews in Cardiovascular Medicine
|November 10, 2009
PubMed

Insights

Optimal medical therapy effectively manages chronic coronary artery disease (CAD) and stable angina, matching revascularization outcomes. Guidelines will update to reflect these findings for better patient care.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Evidence-Based Practice

Background:

  • Chronic coronary artery disease (CAD) and stable angina require symptom relief and improved clinical outcomes.
  • Current guidelines emphasize evidence-based therapies, with regular updates incorporating new data.
  • Since 2002, pivotal studies have supported aggressive, optimal medical therapy for chronic CAD.

Purpose of the Study:

  • To review the role of optimal medical therapy in chronic CAD and stable angina.
  • To highlight recent findings comparing medical therapy with revascularization.
  • To anticipate guideline modifications based on new evidence.

Main Methods:

  • Review of pivotal studies and guideline updates.
  • Analysis of recent landmark studies on medical therapy versus revascularization.
  • Synthesis of evidence for treatment recommendations.

Main Results:

  • Optimal medical therapy is crucial for symptom relief and improved outcomes in chronic CAD.
  • Two landmark studies show optimal medical therapy is as effective as percutaneous coronary intervention or coronary artery bypass grafting.
  • These studies reduce the risk of adverse clinical outcomes.

Conclusions:

  • Optimal medical therapy is a cornerstone in managing chronic CAD and stable angina.
  • Future guidelines (2009-2010) are expected to incorporate these findings.
  • Recommendations will likely shift towards emphasizing optimal medical therapy's efficacy.

More Related Videos

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Related Concept Videos

Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...